Discover How Helix is Changing the World of Healthcare

Resources Hub

Helix and Cone Health Launch Population Genomics Initiative

Press Releases

Nov 7, 2023

Helix and Cone Health Launch Population Genomics Initiative

Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers

Research

Nov 1, 2023

Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers

News

Oct 31, 2023

What to Know About the JN.1 Variant

Delivering a Real-time Genomics OS to Healthcare

News

Oct 18, 2023

Delivering a Real-time Genomics OS to Healthcare

Inside Precision Medicine

Poster: Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claims

Research

Oct 17, 2023

Poster: Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claims

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Research

Oct 11, 2023

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Genetic Testing Identifies More Familial Hypercholesterolemia Cases and Reduces Healthcare Costs

Blog

Sep 28, 2023

Genetic Testing Identifies More Familial Hypercholesterolemia Cases and Reduces Healthcare Costs

Navigation Precision Health with Population Genomics

Webinars

Aug 23, 2023

Navigation Precision Health with Population Genomics

Nebraska Medicine & Helix Partner to Provide Precision Care in Nebraska to Help Find Health Issues Individually and Statewide

Press Releases

Aug 15, 2023

Nebraska Medicine & Helix Partner to Provide Precision Care in Nebraska to Help Find Health Issues Individually and Statewide

The Latest Content From Helix

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Recent Press Releases

View All Press Releases

Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

May 28, 2025

Press Releases

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

March 18, 2025

Press Releases

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

March 13, 2025

Recent Published Research

View All Published Research

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

June 10, 2025

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

March 19, 2025

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

March 19, 2025

Published Research

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

March 19, 2025

Published Research

Discover How Helix is Changing the World of Healthcare

Resources Hub

The Latest Content From Helix

Recent Blog Posts

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Mental Health Awareness Month: Advancing Empathy and Personalization in Care

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Recent Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Recent Videos

Partner Perspectives with Nebraska Medicine

Partner Perspectives with MUSC - Update

Partner Perspectives with Renown Health - Update

Recent Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

Recent Whitepapers

Performance and Applications of Helix Exome+®​ Assay

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Get in touch

The Latest Content From Helix

Recent Blog Posts

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Mental Health Awareness Month: Advancing Empathy and Personalization in Care

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Recent Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Recent Videos

Partner Perspectives with Nebraska Medicine

Partner Perspectives with MUSC - Update

Partner Perspectives with Renown Health - Update

Recent Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

Recent Whitepapers

Performance and Applications of Helix Exome+®​ Assay

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Performance and Applications of Helix Exome+^® Assay

Performance and Applications of Helix Exome+^® Assay